APA (7th ed.) Citation

Takai, S., Nishida, H., Ito, H., Fukuhara, H., Nawano, T., Narisawa, T., . . . Tsuchiya, N. (2022). Immunogenicity and safety of two doses of SARS‐CoV‐2 mRNA vaccine in kidney transplant recipients with low‐dose rituximab. International Journal of Urology, 29(11), 1279. https://doi.org/10.1111/iju.14978

Chicago Style (17th ed.) Citation

Takai, Satoshi, et al. "Immunogenicity and Safety of Two Doses of SARS‐CoV‐2 MRNA Vaccine in Kidney Transplant Recipients with Low‐dose Rituximab." International Journal of Urology 29, no. 11 (2022): 1279. https://doi.org/10.1111/iju.14978.

MLA (9th ed.) Citation

Takai, Satoshi, et al. "Immunogenicity and Safety of Two Doses of SARS‐CoV‐2 MRNA Vaccine in Kidney Transplant Recipients with Low‐dose Rituximab." International Journal of Urology, vol. 29, no. 11, 2022, p. 1279, https://doi.org/10.1111/iju.14978.